Compare PLSE & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | UEC |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | 257 |
| Industry | Medical/Dental Instruments | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.6B |
| IPO Year | 2015 | 2008 |
| Metric | PLSE | UEC |
|---|---|---|
| Price | $53.80 | $7.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $60.67 | $16.03 |
| AVG Volume (30 Days) | 401.8K | ★ 9.1M |
| Earning Date | 11-05-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $37,250,000.00 |
| Revenue This Year | $480.71 | $70.84 |
| Revenue Next Year | $177.98 | $178.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $7.27 |
| 52 Week High | $58.90 | $20.34 |
| Indicator | PLSE | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 28.82 |
| Support Level | $49.01 | $7.27 |
| Resistance Level | $55.36 | $10.31 |
| Average True Range (ATR) | 3.43 | 0.48 |
| MACD | 0.37 | -0.07 |
| Stochastic Oscillator | 88.36 | 18.13 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Uranium Energy Corp is engaged in uranium mining and related activities, including exploration, permitting, pre-extraction, extraction, recovery, and processing. The Company undertakes conventional and ISR uranium extraction and recovery and the exploration, permitting, and evaluation of uranium properties in the United States, Canada, and the Republic of Paraguay. Its principal projects are located in Wyoming and Texas in the United States and Saskatchewan, Canada. The Company operates three hub-and-spoke platforms in South Texas and Wyoming, anchored by licensed CPPs and served by ISR and conventional uranium projects. Its operating segments consist of uranium exploration and mining activities in Wyoming, Texas, Saskatchewan, and others, with Wyoming generating maximum revenue.